LGK974

WNT974 · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LGK974, covering 2025-06-13 to 2025-06-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands [Phase 1]